Safety and Efficacy of Glecaprevir/Pibrentasvir in Chronic Kidney Disease, Compensated Cirrhosis and Non-Cirrhosis. CDF [Internet]. 2025 Feb. 3 [cited 2025 Oct. 12];54(3):883-94. Available from: https://cuestionesdefisioterapia.com/index.php/es/article/view/1204